scholarly journals Setting Research Priorities for Cervical Cancer Prevalence, Prevention and Treatment in WHO Africa Region

2021 ◽  
Vol 09 (01) ◽  
pp. 41-49
Author(s):  
Leopold Ouedraogo ◽  
Triphonie Nkurunziza ◽  
Kim Caron Rahn ◽  
Ali Moazzam ◽  
Tolu Lemi ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Research Priorities ◽  
Cancer Prevalence ◽  
Prevention And Treatment

scholarly journals From the Infection to the Immunotherapy in Cervical Cancer: Can We Stop the Natural Course of the Disease?

Vaccines ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 597
Author(s):  
Daniela Luvero ◽  
Salvatore Lopez ◽  
Giorgio Bogani ◽  
Francesco Raspagliesi ◽  
Roberto Angioli
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Risk Factor ◽  
Hpv Vaccine ◽  
Global Market ◽  
Cancer Death ◽  
Prevention Measures ◽  
Primary And Secondary Prevention ◽  
The World ◽  
Prevention And Treatment

Cervical cancer (CC) is the second leading cause of cancer death in women aged 20–39 years. Persistent infection with oncogenic types of human papillomavirus (HPV) represents the most important risk factor for the development of cervical cancer. Three HPVs vaccines are currently on the global market: bivalent, quadrivalent, and nonavalent. The nonavalent vaccine provides protection against almost 90% of HPV-related CC. Despite availability of primary and secondary prevention measures, CC persists as one of the most common cancers among women around the world. Although CC is a largely preventable disease, management of persistent or recurrent CC no longer amenable to control with surgery or radiation therapy has not improved significantly with the progress of modern chemotherapy and disseminated carcinoma of the cervix remains a discouraging clinical entity with a 1-year survival rate between 10% and 15%. Over the last few years, there has been increasing interest in immunotherapy as a strategy to fight tumors. This article focuses on recent discoveries about the HPV vaccine and immunotherapies in the prevention and treatment of CC, highlighting the future view.

The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment

2018 ◽  
Vol 122 ◽  
pp. 92-97 ◽  
Author(s):  
Giorgio Bogani ◽  
Umberto Leone Roberti Maggiore ◽  
Mauro Signorelli ◽  
Fabio Martinelli ◽  
Antonino Ditto ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cancer Prevention ◽  
Cervical Cancer Prevention ◽  
Papillomavirus Vaccines ◽  
Human Papillomavirus Vaccines ◽  
Prevention And Treatment

scholarly journals Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective

2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Sarah Finocchario-Kessler ◽  
Catherine Wexler ◽  
May Maloba ◽  
Natabhona Mabachi ◽  
Florence Ndikum-Moffor ◽  
...  
Keyword(s):  
Public Health ◽  
Systematic Review ◽  
Cervical Cancer ◽  
Cancer Prevention ◽  
Cervical Cancer Prevention ◽  
Public Health Perspective ◽  
Prevention And Treatment ◽  
Treatment Research

Cervical Cancer: Definition, Prevention and Treatment

2019 ◽  
Vol 01 (01) ◽  
Author(s):  
Mari Uyeda ◽  
abian Friedrich ◽  
Antonio Cassio Assis Pellizzon
Keyword(s):  
Cervical Cancer ◽  
Prevention And Treatment

Cervical cancer in the Russian Federation and the risks of vaginal fistula

2021 ◽  
Vol 11 (2) ◽  
pp. 49-54
Author(s):  
M. N. Saryev ◽  
R. K. Valiev ◽  
M. I. Nechushkin ◽  
M. B. Nurberdyev ◽  
I. V. Panichenko ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Russian Federation ◽  
Vaginal Fistula ◽  
Factors Associated ◽  
Increased Risk ◽  
Relevant Task ◽  
Prevention And Treatment ◽  
Oncological Diseases ◽  
The Russian Federation

This review aims to provide up-to-date information on the factors associated with an increased risk of vaginal fistula in women with cervical cancer, as well as on methods of their prevention and treatment. It includes data on various types of vaginal fistulas in cervical cancer patients and risk factors for their development, according to foreign and Russian research articles published over the last 20 years. Cervical cancer is one of the most challenging oncological diseases in the Russian Federation, because it is detected at stage III–IV in more than 30 % of women. Such a high incidence of cervical cancer and the need for radiotherapy determine high risk of fistulas, which significantly impairs the quality of life. Thus, identification of factors associated with vaginal fistulas, as well as methods of their prevention and treatment remains a highly relevant task for the Russian healthcare system.

scholarly journals Assessment of knowledge, awareness and preventive measures of cervical cancer among female medical students

2016 ◽  
Vol 15 (4) ◽  
pp. 583-587
Author(s):  
Takkella Nagamma ◽  
Vincent Loo Boon Seng ◽  
Cally Choi Pui Leng ◽  
Noor Aliahbinti Alias ◽  
Najwabinti Abdul Karim
Keyword(s):  
Risk Factors ◽  
Cervical Cancer ◽  
Medical Students ◽  
Pap Smear ◽  
Medical Science ◽  
Female Students ◽  
Pap Smear Test ◽  
Smear Test ◽  
Validated Questionnaire ◽  
Prevention And Treatment

Objectives: The main objective of the study to evaluate the knowledge about cervical cancer causes, vaccination and treatment among female medical students.Materials and Methods: It was a cross sectional study conducted in Melaka Manipal Medical College (Manipal campus), Manipal during October 2012 to April 2013. This study included 194 female medical students from MBBS and BDS undergraduate courses. Data were collected by using validated questionnaire. Data were analysed by SPSS 16 Software.Results The present results shows that the female students demonstrated good knowledge about cervical cancer, pap smear test, prevention and treatment. Among the respondents 97% had heard about cervical cancer, only 3% of female students had the family history of cervical cancer. However many students are did not know that smoking (34%), many child birth (40%) and usage of oral contraceptives (38%) are the risk factors for the cervical cancer.Conclusion: The present study shows adequate levels of knowledge and awareness about pap smear test, prevention and treatment of cervical cancer. Many of the students they did not have the adequate knowledge about risk factors of cervical cancer. This study indicates that further educational programs, especially about risk factors, needed in female medical students.Bangladesh Journal of Medical Science Vol.15(4) 2016 p.583-587

Screening, prevention and treatment of cervical cancer—A global and regional generalized cost-effectiveness analysis

Vaccine ◽  
2009 ◽  
Vol 27 (43) ◽  
pp. 6060-6079 ◽  
Author(s):  
Gary Michael Ginsberg ◽  
Tessa Tan-Torres Edejer ◽  
Jeremy A. Lauer ◽  
Cecilia Sepulveda
Keyword(s):  
Cervical Cancer ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
Prevention And Treatment ◽  
Generalized Cost
Sign in / Sign up

Export Citation Format

Share Document